Omeprazole in infants with cimetidine-resistant peptic esophagitis
- PMID: 9506656
- DOI: 10.1016/s0022-3476(98)70460-3
Omeprazole in infants with cimetidine-resistant peptic esophagitis
Abstract
Twelve neurologically normal infants (age 2.9+/-0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources